I. MODIFIED AGREEMENTS

Company*
(Country;
Symbol)

Company*
(Country;
Symbol)

Change from
original agreement

Terms/Details (Date)


Cytomedix
Inc.
(OTC BB:CYME)

Harvest Technologies Inc.*

They resolved litigation related to Cytomedix's platelet gel technology

A license has been granted to Harvest as part of the settlement; further terms were not disclosed (5/24)

NiKem Research
Srl*
(Italy)

Hybrigenics
SA*
(France)

They expanded and extended a research services agreement

NiKem will continue to provide medicinal chemistry services to optimize inhibitors of ubiquitin-specific proteases for use as cancer agents (5/9)


Notes:

* Private companies are indicated with an asterisk.

Unless otherwise noted, stock symbols listed are on the Nasdaq market.

OTC BB = Over-the-Counter Bulletin Board.